• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG M.BLUE PLUS SYS W/CONTROL RESERVOIR; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG M.BLUE PLUS SYS W/CONTROL RESERVOIR; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FX824T
Medical Device Problem Code Obstruction of Flow (2423)
Health Effect - Clinical Code Hydrocephalus (3272)
Date of Event 03/01/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that an m.Blue plus(#fx824t) was implanted during a procedure performed on (b)(6) 2025.According to the complainant, the shunt system caused an underdrainage.The patient underwent a revision procedure on (b)(6) 2025.No patient complications were reported as a result of the revision procedure.The complained product was sent to the manufacturer for investigation.
 
Additional Manufacturer Narrative
Visual inspection: during the investigation, no significant deformations or damages of the valves were determined.Permeability test: a permeability test has shown that both valves are permeable.Computer controlled test: to investigate the claim of under-drainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valves are tested in both the horizontal as well as the vertical position.The result shows that the progav 2.0 operates within the accepted tolerances in the horizontal position.However, the m.Blue does not operate within the specified tolerances in the vertical position.A tendency for an accelerated outflow of the m.Blue could be determined.Adjustment test: the valves were tested and both valves are adjustable in all pressure settings.Braking force and brake function test: the brake functionality test has shown that the brake function operates as expected and the braking force is within the given tolerance.Internal inspection: after dismantling of the valves, organic deposits were found in m.Blue.Results: based on our investigation results, we can determine a tendency towards accelerated flow at the m.Blue.The deposits, some of which are visible in the valve, have led to the change in the flow rate.We cannot detect any functional deviations or other anomalies on the progav 2.0 and the control reservoir.The components work within the specifications.Deposits caused by natural substances in the body, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.Even small amounts of organic deposits can impair the integrity of the valve.When valves are opened, it is possible to see a large part of the interior.However, there are areas that cannot be examined visually.These areas may contain organic deposits that can impair the function.It is also possible that deposits are already flushed out when the valve is flushed on the test bench.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
M.BLUE PLUS SYS W/CONTROL RESERVOIR
Common Device Name
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
Manufacturer (Section G)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM   14469
Manufacturer Contact
joerg knebel
ulanenweg 2
potsdam, 14469
GM   14469
MDR Report Key21730337
Report Number3004721439-2025-00086
Device Sequence Number19828785
Product Code JXG
UDI-Device Identifier04041906504830
UDI-Public4041906504830
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
K192266
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Device Explanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 03/31/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberFX824T
Device Catalogue NumberFX824T
Device Lot Number20079916
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/10/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/10/2025
Initial Report FDA Received Date03/31/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/15/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age59 YR
Patient SexMale
Patient Weight70 KG
-
-